Menu

Bronze Age Plague Sequenced

Plague-causing bacteria may have been around as early as 5,000 years ago, though a genomic analysis suggests that ancient strains were less contagious.

Oct 26, 2015
Karen Zusi

RASMUSSEN ET AL./CELL 2015

Plague bacteria (Yersinia pestis) were recently discovered in Bronze Age skeletons, pushing back the recorded origin of plague by about 3,000 years. The newfound ancient strains are genetically distinct from modern-day strains. An international team reported its findings last week (October 22) in Cell.

Researchers led by Eske Willerslev of the University of Copenhagen were searching for the cause of Bronze Age human migrations in Europe and Asia, circa 3,000 BC to 1,000 BC, suspecting that disease might have been a driving factor. So the team sequenced 89 billion DNA sequences from 101 Bronze Age specimens obtained from museums and excavations.

Seven of the specimens contained Y. pestis DNA. Most of the ancient bacterial genomes lacked a gene known to protect the pathogen while it’s inside the flea gut, suggesting that the plague was not spread easily by fleas. The ancient Y. pestis bacteria also lacked a mutation that helps present-day strains avoid detection by the host’s immune system. The authors suggest that Y. pestis did not evolve into its destructive flea-borne form until the beginning of 1,000 BC.

“It’s really cool that they can pinpoint the acquisition of key genes that allow the movement of this bacteria into fleas,” evolutionary geneticist Hendrik Poinar of McMaster University in Canada, who was not involved with the study, told Science.

“At that time we have a kind of intermediate plague,” study coauthor Simon Rasmussen from the Technical University of Denmark told Smithsonian. “These Bronze Age strains couldn't cause bubonic plague, but they caused septicemic plague in the blood and pneumonic plague in the lungs, which you can transmit through the air whenever you sneeze or cough.”

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.